A new market study, titled “Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis – Forecast to 2026”, has been featured on WiseGuyReports.
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report also covers some of the hot targets in research for NASH treatments and NASH related biomarkers.
This report enables Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Non-alcoholic steatohepataitis (NASH) drugs market.
Request Sample Report at https://www.wiseguyreports.com/sample-request/3322833-nonalcoholicsteatohepatitis-nash-pipeline-analysis-forecast-to-2026
The report also provides strategic insights on some of the molecules that are yet to be launched in the next few years. Some of the key sections covered in the report are given below:
- Epidemiology
o In this section, epidemiology of NASH is reviewed to understand potential significance and impact of the disease.
o Global & US prevalence rates.
- Hot Targets, Mechanisms & Therapies
o In this section, various NASH associated targets, mechanism and upcoming therapies are discussed. Also, covers novel targets in early research for NASH along with disease progression biomarkers associated with NASH (Inflammatory, apoptosis, fibrosis).
- Pipeline Analysis
o Pipeline analysis was carried to get deeper insights on various treatment modalities in discovery, preclinical & development section, pipelines from major companies were identified and Potential targets were reported along with Mechanism of action, Current development status & nature of molecule. Pipeline analysis by developmental stage (Discovery to Clinical development).
o Pipeline analysis by modalities
- Monoclonal Antibodies pipeline analysis
- RNA-therapeutics pipeline analysis
- Recombinant protein pipeline analysis
o Pipeline analysis by leading players & Target analysis
o Drug analysis based on mechanism (Anti-Inflammatory, Anti-fibrotic and Metabolic)
View Detailed Report at https://www.wiseguyreports.com/reports/3322833-nonalcoholicsteatohepatitis-nash-pipeline-analysis-forecast-to-2026
Table of Content
REPORT DESCRIPTION INTRODUCTION
- Causes & Symptoms
- Diagnosis
- Unmet needs
- Current therapies
HOT TARGETS, MECHANISMS & THERAPIES
- Novel Disease mechanisms & therapies
- Leading targets of NASH
- Novel targets of NASH
- NASH biomarkers
- Genes involved in NASH
MARKET DATA
- Forecasting model
- Market dynamics
- Market sizing and peak sales
- NASH Deals
- Funding Scenario
PIPELINE ANALYSIS
- Development stage
- Leading players
- Molecule Type
- Target analysis
- Clinical Update on Phase 3 molecules
- Innovative approaches
Small molecules
- Pipeline
- Competitive landscape
Large molecules
- RNA-BASED THERAPY
- Pipeline
- Competitive landscape
- RECOMBINANT PROTEINS
- Pipeline
- Competitive landscape
- ANTIBODIES
- Pipeline
- Competitive landscape
- Pipeline
LARGE MOLECULES (UNSPECIFIED)
Pipeline
OTHER MOLECULES
Pipeline
NASH DRUG ANALYSIS BASED ON MECHANISM (CLINICAL)
MAJOR PLAYERS
- Company Profiles
- Overview, Pipeline & Deals
REFERENCE
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.